gonorrhea
Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test
The point-of-care assay to detect and differentiate chlamydia, gonorrhea, and mycoplasma infections from a single sample will now be commercially available in the US in coming months.
Kryptos Biotechnologies Gets $1.2M Grant From RIGHT Foundation for Rapid STI Test
The funding will support optimization of a PCR-based test system and development of a 30-minute test to detect chlamydia, gonorrhea, and trichomoniasis.
CARB-X Grants Melio $3.5M for Neonatal Sepsis Test, Visby Wins Additional $3.9M
The Melio funding will support a diagnostic test using acoustic sample prep and melt curve detection.
The firm plans to apply more than $10 million in recent Gates Foundation grants toward regulatory submission of a rapid STI test.
The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.